Following the announcement of the Bill and Melinda Gates Foundation’s new open access policy, Richard Sever assesses whether this change signals the beginning of a wider preprint-led open access transition. … Read More →
Open Access and Closed Research. Who benefits from the APC?
Recent research published in Scientometrics raises questions about unforeseen consequences of the spread of Open Access scientific publishing that have to do with the growth of total expenditures and who would be the economic beneficiaries of this paradigm shift. … Read More →
Open Access Plans — S, T, U, so far
Things do seem to be moving in Open Access (OA). First there was Plan S, proposed by science funders in the European Union, then a proposal to fund OA from submission fees rather than article processing charges, (perhaps flippantly) called Plan T, and now, in alphabetical sequence, Plan U. All three have strong merits, but Plan U has the best chance of succeeding and offers the most to the scientific community. … Read More →
What is Plan U: Universal access to scientific research via preprints?
Plan U proposes that funding agencies require recipients of research funds to publish scholarly communications on preprints servers, regardless of the alternative publication forms that researchers may subsequently make. The initiative could be carried out with a fraction of the current costs and would produce a significant acceleration of the pace of discoveries in the forthcoming years. … Read More →
At age 50, BIREME is face to face with the new librarianship
The perspective of equity access to health scientific information that motivated twenty years ago the creation and development of the Virtual Health Library is becoming a reality. However, at BIREME’s 50th Anniversary, the scope and functions of librarianship and information science are as tensioned as they were two decades ago for the advance of open science and Sustainable Development Goals. … Read More →
How do researchers and journalists in Brazil relate to each other?
Scientists admit that dealing with complex issues related to their research with journalists is not an easy task. However, long they realized that communicate their results in scientific journals is not enough. To obtain research grants, attract collaboration opportunities and for career advancement, it is necessary – and advisable – to communicate with the public through journalists. Read about the details of this relationship and what can be done to improve it. … Read More →
The Open Data movement: international consolidation
The open data movement – the availability of scientific research data for preservation, searching, using and citing – is gaining followers in all sectors of the academic world, and with editors, publishers, research institutions and funding agencies. The movement will allow greater interoperability, transparency, visibility and research impact, in addition to ensuring the digital preservation of the original data that would otherwise have a tendency to be lost or become inaccessible with the passage of time. … Read More →
South America science in Nature
The celebrated journal Nature devotes a special section of its June 11 issue to an analysis of South American research output, highlighting areas of excellence and innovation which are internationally recognized, and fields of collaboration with other countries both inside and outside the region. The articles in this section stress the economic and infrastructural inequalities within the region, as well as the low levels of investment in research and development, and point to FAPESP as a successful model of investment directly linked to a state’s GDP. … Read More →
The EU will centralize the registry of clinical trials
In April 2014, the European Union approved legislation regulating the registry of clinical trials. This will allow for transnational cooperation between laboratories and institutions of research. The measure will contribute to the transparency and dependability of the trials, and will also allow research into drugs for the treatment of rare diseases. The first registry of clinical trials was created by the WHO in 2004. Currently, registering clinical trials is mandatory in the majority of the countries. … Read More →
Recent Comments